Ann Wiegand

Ann Wiegand

UNVERIFIED PROFILE

Are you Ann Wiegand?   Register this Author

Register author
Ann Wiegand

Ann Wiegand

Publications by authors named "Ann Wiegand"

Are you Ann Wiegand?   Register this Author

32Publications

659Reads

40Profile Views

Ongoing HIV Replication During ART Reconsidered.

Open Forum Infect Dis 2017 19;4(3):ofx173. Epub 2017 Sep 19.

Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofx17
Publisher Site
http://dx.doi.org/10.1093/ofid/ofx173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172598PMC
September 2017

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.

PLoS Pathog 2017 03 22;13(3):e1006283. Epub 2017 Mar 22.

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1006283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378418PMC
March 2017

Single-copy quantification of HIV-1 in clinical samples.

Methods Mol Biol 2014 ;1087:251-60

HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-62703-670-2_20DOI Listing
May 2014

Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.

J Infect Dis 2009 Sep;200(6):984-90

The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, 149 13th St, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/605446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725728PMC
September 2009

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Proc Natl Acad Sci U S A 2008 Mar 10;105(10):3879-84. Epub 2008 Mar 10.

HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0800050105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268833PMC
March 2008

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

Lancet 2005 Aug 13-19;366(9485):549-55

University of Texas Southwestern Medical Center at Dallas, Department of Medicine, Division of Infectious Diseases, 5323 Harry Hines Boulevard, Dallas, TX 753901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(05)67098-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1894952PMC
October 2005